Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: BrsaItaliana
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Recordati SpA

+ Add to Watchlist

REC:IM

16.1200 EUR 0.1200 0.74%

As of 11:30:33 ET on 03/03/2015.

Snapshot for Recordati SpA (REC)

Open: 16.3100 Day's Range: 16.0100 - 16.5600 Volume: 226,791
Previous Close: 16.2400 52wk Range: 11.1200 - 16.5600 1-Yr Rtn: +27.47%

Stock Chart for REC

No chart data available.
  • REC:IM 16.1000
  • 1D
  • 1M
  • 1Y
16.2400
Interactive REC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for REC

Current P/E Ratio (ttm) 20.5893
Estimated P/E(12/2015) 18.7879
Relative P/E vs. FTSEMIB 0.3336
Earnings Per Share (EUR) (ttm) 0.7829
Est. EPS (EUR) (12/2015) 0.8580
Est. PEG Ratio 3.0450
Market Cap (M EUR) 3,371.10
Shares Outstanding (M) 209.13
30 Day Average Volume 291,028
Price/Book (mrq) 4.0234
Price/Sale (ttm) 3.3522
Dividend Indicated Gross Yield 2.30%
Cash Dividend (EUR) 0.2600
Dividend Ex-Date 11/17/2014
5 Year Dividend Growth 8.16%
Next Earnings Announcement 05/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for REC

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for REC

Recordati S.p.A. manufactures pharmaceuticals. The Company researches,develops, manufactures, and markets prescription and non-prescription pharmaceuticals, pharmaceutical chemicals, therapeutic products and rare disease treatments. The Company sells its products throughout the world.

Giovanni RecordatiChairman/CEOAlberto RecordatiVice Chairman
Fritz SquindoManaging Director/CFOAndrea RecordatiChief Operating Officer
More Company Profile & Key Executives for REC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil